Background Percutaneous coronary intervention (PCI) is increasingly used to treat unprotected
left main coronary artery stenosis, although coronary-artery bypass grafting (CABG) has …

Background The potential benefits and risks of the use of dual antiplatelet therapy beyond a
12-month period in patients receiving drug-eluting stents have not been clearly established. …

Background Most trials comparing percutaneous coronary intervention (PCI) with coronary-artery
bypass grafting (CABG) have not made use of second-generation drug-eluting stents. …

Percutaneous coronary intervention with stenting is the most widely performed procedure
for the treatment of symptomatic coronary disease, and drug-eluting stents (DES) have …

Objective: To study the relationship of echocardiographic epicardial adipose tissue (EAT)
with coronary artery disease (CAD) risk factors and the extent of coronary atherosclerosis. …

Purpose We sought to assess the frequency and clinical implications of left ventricular apical
ballooning (LVAB) in patients who had been admitted to the medical ICU for noncardiac …

Background— We report findings from optical coherence tomography (OCT) of in-stent
neoatherosclerosis as a cause of drug-eluting stent (DES) failure. Methods and Results— Optical …

Objectives : We performed the long-term follow-up of a large cohort of patients in a multicenter
study receiving left main coronary artery (LMCA) revascularization. Background : Limited …

Background— The risks and benefits of long-term dual antiplatelet therapy remain unclear.
Methods and Results— This prospective, multicenter, open-label, randomized comparison …

Objectives : The goal of this study was to identify clinical and lesion-specific local factors
affecting visual-functional mismatch. Background : Although lesion severity determined by …